Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vomiting 7Nausea 7Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Seminoma 1Lymphoma, Non-Hodgkin 1Inflammatory Breast Neoplasms 1Hematologic Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Cisplatin 6Etoposide 5Ifosfamide 4Bleomycin 4Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Carboplatin 3Vinblastine 2Paclitaxel 2Filgrastim 2Cyclophosphamide 2lerisetron 1Oxaliplatin 1Moxifloxacin 1Magnetic Resonance Spectroscopy 1Levofloxacin 1Granisetron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Testicular Germ Cell Tumor × Granisetron × Clear all
NCT00004219 2013-08-02

Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma

National Cancer Institute (NCI)

Phase 3 Unknown
150 enrolled
Genitourinary

Testicular Germ Cell Tumor, Nausea, Testicular Neoplasms, Vomiting, Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡